Open AccessHuman embryonic stem cell therapy for aplastic anemia
Author(s) -
Shroff Geeta,
Gupta Rakesh,
Zadeng Lalduhawmi
Publication year - 2017
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.950
Subject(s) - medicine , embryonic stem cell , aplastic anemia , stem cell , stem cell therapy , cell therapy , cancer research , pathology , transplantation , microbiology and biotechnology , bone marrow , biology , genetics , gene
Key Clinical Message Human embryonic stem cell (hESC) therapy is the potential therapeutic option for the treatment of patients with aplastic anemia (AA). The study showed a remarkable improvement in the AA patient subsequent to hESC administration. No adverse events occurred in the patient. hESC therapy is safe and effective for AA patients.